More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
Haploidentical hematopoietic can be conducted on an outpatient basis but the two main reasons to accept into the hospital a patient in this setting are complications of the hematological toxicity and/or the cytokine-release syndrome. With the aim of reducing the post-transplant cyclophosphamide-depe...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Taylor & Francis Group
2024-12-01
|
| Serie: | Hematology |
| Ämnen: | |
| Länkar: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2313357 |